Co-funded by the European Union

Sanofi announced a global programme for employees affected by cancer or a serious illness

  • On 5 February 2024, Sanofi unveiled "Cancer and Work: Acting Together," a comprehensive global programme to support employees diagnosed with cancer or other serious illnesses. 
  • This initiative ensures job security, salary continuation, and social benefits for at least twelve months, regardless of the employee's role or location, marking a significant step forward in corporate responsibility and employee welfare.

Beyond financial aid, the programe offers flexible working conditions, emotional support, access to a network of trained volunteer colleagues, and external psychological counseling available 24/7.

The company aims to integrate coverage for various non-medical expenses into its health benefits plans, including provisions for wigs, and introduce unpaid family solidarity leave for employees to care for seriously ill relatives.

The programme provides an approach to flexible work schedules and emotional support, including a global network of affinity groups and access to psychological counseling, confirming a solid commitment to holistic employee well-being. Additionally, the initiative aims to equip managers with the knowledge and resources to support team members effectively, fostering an inclusive workplace culture that accommodates employees' health needs.

As highlighted in the press release, the initiative originates from a grassroots movement within Sanofi, France, in 2017 and then expanded to a global scale. 

It also responds to the broader challenge of cancer's impact on employment. It represents a forward-thinking approach to employee health and well-being, setting a benchmark for global corporations in corporate social responsibility and employee support.

Here you can find a recent news on similar initiative in L’Oreal.